Microparticle chroma clustering analysis method and kit
A technology of cluster analysis and microparticles, applied in the field of biomedicine, can solve problems such as difficult cost reduction, interference, and high cost performance, and achieve low cost, low cost, and good detection sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0056] Identification of Common Unexpected Antibodies in Human Blood Types by Microparticle Chromatic Cluster Analysis
[0057] Human blood group accidental antibody refers to the immune antibody produced by the body against the blood group antigen or antigen subtype that it does not have after blood transfusion and pregnancy. May cause hemolytic disease of the newborn in the fetus. Therefore, accidental antibody screening and identification of unexpected antibodies are important tests for blood transfusion and pregnancy testing. At present, accidental antibody screening and accidental antibody identification are two detection items. First, the antibody screening reagent cells are used to react with the specimen to be tested. If there is agglutination, it means that there is an unexpected antibody, and if there is no agglutination, it means that there is no unexpected antibody; In this case, it is necessary to use a group of antibodies to identify the reagent cells to react w...
Embodiment 2
[0072] Detection of tumor markers by microparticle chromaticity cluster analysis
[0073] Tumor is a common and frequently-occurring disease, which seriously endangers the life safety of patients. Laboratory diagnosis is an important method to detect tumors early and win treatment opportunities for patients. Due to the diversity of tumors, it is often necessary to conduct joint detection of dozens of tumor markers at the same time in order to find tumors with a broad spectrum. In this embodiment, the high-efficiency detection of tumor markers is realized by utilizing the multi-analyte detection capability of the microparticle chromaticity cluster analysis method and the high-throughput detection capability of specimens. Since dozens of tumor markers have been discovered, for ease of expression, this example only uses the most common alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), neuron-specific enolase (NSE) Detection of seven tumor markers, including squamous cell...
Embodiment 3
[0088] Infection Screening of Blood Donors Using Microparticle Chromatic Cluster Analysis
[0089] In order to avoid blood transfusion-transmitted diseases, it is an international practice in the blood collection and supply industry to screen blood donor samples for pathogens transmitted by blood. The mandatory screening items stipulated by Chinese laws and regulations include HIV-1 antibody, HIV-p24, HBsAg, HCV antibody and TP antibody Blood banks often need to repeat the above screening for dozens or even hundreds of blood donors at the same time. In this embodiment, the multi-analyte detection capability and the high-throughput detection capability of specimens of the microparticle chromaticity cluster analysis method are used to realize infection screening of blood donors. For the convenience of expression, in this embodiment, the HIV-GP41 antibody is used as the representative of the HIV-1 antibody, the HCV-NS3 antibody is used as the representative of the HCV antibody, a...
PUM
Property | Measurement | Unit |
---|---|---|
Diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com